|Last Price$105.77||Day Change (%)-0.64%|
|Open Price$106.50||Day Change ($)-0.68|
|Day Range105.33–106.50||52-Week Range75.00–110.01|
As of Tue 7/26/2016 7:14:00 PM | USD
Ipsen and its Partner Exelixis Receive Positive CHMP Opinion for Cabometyx™ (Cabozantinib) for the Treatment of Advanced RCC in Adults Following Prior VEGF-Targeted Therapy
Robbins Arroyo LLP: Insmed, Inc. (INSM) Misled Shareholders According to a Recently Filed Class Action
FDA Grants Priority Review for Genentech’s OCREVUS™ (ocrelizumab) Biologics License Application
The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...